- Home
- RPTX vs CCIF Comparison
RPTX vs CCIF Comparison
Compare RPTX & CCIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- CCIF
- Stock Information
- Founded
- RPTX 2016
- CCIF 2011
- Country
- RPTX Canada
- CCIF United States
- Employees
- RPTX N/A
- CCIF N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- CCIF Finance/Investors Services
- Sector
- RPTX Health Care
- CCIF Finance
- Exchange
- RPTX Nasdaq
- CCIF Nasdaq
- Market Cap
- RPTX 141.1M
- CCIF 110.5M
- IPO Year
- RPTX 2020
- CCIF N/A
- Fundamental
- Price
- RPTX $1.32
- CCIF $7.94
- Analyst Decision
- RPTX Strong Buy
- CCIF
- Analyst Count
- RPTX 3
- CCIF 0
- Target Price
- RPTX $7.00
- CCIF N/A
- AVG Volume (30 Days)
- RPTX 664.3K
- CCIF 76.9K
- Earning Date
- RPTX 11-07-2024
- CCIF 01-01-0001
- Dividend Yield
- RPTX N/A
- CCIF 25.90%
- EPS Growth
- RPTX N/A
- CCIF N/A
- EPS
- RPTX N/A
- CCIF N/A
- Revenue
- RPTX $66,524,000.00
- CCIF N/A
- Revenue This Year
- RPTX $13.22
- CCIF N/A
- Revenue Next Year
- RPTX N/A
- CCIF N/A
- P/E Ratio
- RPTX N/A
- CCIF N/A
- Revenue Growth
- RPTX 18.19
- CCIF N/A
- 52 Week Low
- RPTX $1.23
- CCIF $7.43
- 52 Week High
- RPTX $8.49
- CCIF $10.16
- Technical
- Relative Strength Index (RSI)
- RPTX 30.27
- CCIF 34.15
- Support Level
- RPTX $1.23
- CCIF $8.12
- Resistance Level
- RPTX $4.07
- CCIF $8.25
- Average True Range (ATR)
- RPTX 0.34
- CCIF 0.07
- MACD
- RPTX -0.20
- CCIF -0.02
- Stochastic Oscillator
- RPTX 3.34
- CCIF 1.59
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.
About CCIF Carlyle Credit Income Fund Shares of Beneficial Interest
Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing primarily in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting primarily of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.